Division of Vascular Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
World J Surg. 2020 Jun;44(6):2002-2009. doi: 10.1007/s00268-020-05409-1.
Juxtarenal abdominal aortic aneurysm (AAA) comprises 15-20% of all AAAs and often requires open surgical repair (OSR) due to anatomical limitations associated with endovascular aneurysm repair (EVAR), particularly in the case of hostile proximal necks. This study aimed to evaluate short- and long-term outcomes of suprarenal clamping during OSR of juxtarenal AAAs and compare the outcomes of this technique with those of infrarenal clamping for AAAs.
Between January 1 2014, and December 31 2016, 289 consecutive patients aged ≥40 years underwent primary repair for infrarenal AAAs, including 141 OSRs and 148 EVARs. Of the 141 patients, 20 were excluded and totally, 121 patients were included.
All patients had fusiform-type AAAs and were divided into infrarenal (N = 98) or suprarenal (N=23) clamp groups. The mean follow-up period was 51.4 months (95% CI: 48.6-54.2). Mean survival time was 51.4 months (95% CI: 48.6-54.2). Thirty-day mortality was 0.8%, and there was no significant difference between two groups (P > .999). Renal complication in infrarenal clamp group was 4.1% and suprarenal clamp group was 4.3% (P > .999). Old age (HR: 1.084; 95% CI: 1.025-1.147; P=.005) and high ASA score (HR: 2.361; 95% CI: 1.225-4.553; P = .010) were substantially associated with in-hospital complications.
Although endovascular procedures for repairing juxtarenal AAAs, such as fenestrated EVAR, have been developed, surgical repair is the standard treatment for juxtarenal AAAs. Morbidity and mortality due to open surgery were not higher in the juxtarenal AAA group than in the infrarenal AAA group. Therefore, need for suprarenal clamp should not preclude OSR and also there is continued need for training in surgical exposure of juxtarenal AAA and OSR.
肾周腹主动脉瘤(AAA)占所有 AAA 的 15-20%,由于血管内动脉瘤修复(EVAR)相关的解剖学限制,尤其是在近端颈部敌对的情况下,通常需要开放手术修复(OSR)。本研究旨在评估 OSR 中肾周夹闭治疗肾周 AAA 的短期和长期结果,并将该技术的结果与肾下夹闭治疗 AAA 的结果进行比较。
2014 年 1 月 1 日至 2016 年 12 月 31 日,289 例年龄≥40 岁的患者因腹主动脉瘤接受了原发性修复,其中 141 例接受了 OSR,148 例接受了 EVAR。在 141 例患者中,有 20 例被排除在外,总共纳入 121 例患者。
所有患者均为梭形 AAA,并分为肾下(N=98)或肾周(N=23)夹闭组。平均随访时间为 51.4 个月(95%CI:48.6-54.2)。平均生存时间为 51.4 个月(95%CI:48.6-54.2)。30 天死亡率为 0.8%,两组间无显著差异(P>.999)。肾下夹闭组的肾并发症发生率为 4.1%,肾周夹闭组为 4.3%(P>.999)。高龄(HR:1.084;95%CI:1.025-1.147;P=.005)和高 ASA 评分(HR:2.361;95%CI:1.225-4.553;P=.010)与住院并发症显著相关。
尽管已经开发了诸如开窗 EVAR 等修复肾周 AAA 的血管内手术,但手术修复仍然是肾周 AAA 的标准治疗方法。与肾下 AAA 组相比,开放手术引起的并发症和死亡率在肾周 AAA 组并不高。因此,肾周夹闭的需要不应排除 OSR,并且仍然需要对肾周 AAA 的手术暴露和 OSR 进行培训。